🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I clinical trial evaluates the safety and feasibility of adminis...
Status
Terminated
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2017-07-26
Trial ID
NCT03240861
This phase II trial studies if itacitinib plus standard of care treatment m...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2022-01-11
Trial ID
NCT04859946
End stage renal disease (ESRD) affects approximately 700,000 Americans of w...
Status
Completed
Location
DaVita Columbia University Dialysis
Start Date
2018-05-01
Trial ID
NCT03395366
Treatments Being Tested
This phase II clinical trial studies how well personalized natural killer (...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2016-05-19
Trial ID
NCT02727803
This phase II trial studies how well vorinostat and combination chemotherap...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-10-29
Trial ID
NCT04220008
The main goal of the proposed study is to test whether a successful stress ...
Status
Completed
Location
Jackson Health System
Start Date
2008-12
Trial ID
NCT02272335
Treatments Being Tested
The aim of the study was to develop a Compensation-Based Problem-Solving Th...
Status
Completed
Location
Etlik City Hospital
Start Date
2024-09-01
Trial ID
NCT06717776
Treatments Being Tested
The goal of this research plan is to test the effectiveness of a brief, cog...
Status
Completed
Location
Canandaigua VA Medical Center, Canandaigua, NY
Start Date
2014-10
Trial ID
NCT01771965
Treatments Being Tested
Antibiotic resistant infections are expected to cause 10 million deaths wor...
Status
Unknown
Location
North York General Hospital
Start Date
2018-09
Trial ID
NCT03517215
Treatments Being Tested
This phase II trial studies how well prostate specific membrane antigen (PS...
Status
Recruiting
Location
University of Pittsburgh Cancer Institute (UPCI)
Start Date
2020-09-30
Trial ID
NCT04175431